Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD-008-0045 in Generalized Anxiety Disorder
NCT04524975Phase 2Completed
- Sponsor
- ChemRar High-Tech Center
- Start
- Oct 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Aviandr in generalized anxiety disorder (GAD), sponsored by ChemRar High-Tech Center. Started Oct 2018; status: completed.
02
Drugs
Aviandr
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT04524975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04524975.